| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
21,824 |
16,516 |
$4.69M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29,831 |
22,395 |
$4.18M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12,935 |
6,288 |
$3.75M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
7,108 |
5,046 |
$1.19M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
3,601 |
2,316 |
$1.17M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
2,402 |
1,440 |
$1.05M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,607 |
2,442 |
$800K |
| 71045 |
Radiologic examination, chest; single view |
17,782 |
10,151 |
$638K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,391 |
5,996 |
$571K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,142 |
4,518 |
$497K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
11,141 |
2,549 |
$485K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,894 |
3,551 |
$418K |
| 80053 |
Comprehensive metabolic panel |
50,246 |
35,762 |
$391K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,799 |
4,925 |
$300K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,471 |
3,286 |
$292K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17,712 |
12,429 |
$280K |
| 36415 |
Collection of venous blood by venipuncture |
64,963 |
32,521 |
$269K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
7,360 |
6,059 |
$257K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,412 |
1,471 |
$236K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
36,867 |
29,111 |
$229K |
| 87902 |
|
1,037 |
978 |
$225K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,311 |
5,129 |
$219K |
| G0378 |
Hospital observation service, per hour |
2,974 |
2,436 |
$203K |
| 71046 |
Radiologic examination, chest; 2 views |
5,221 |
4,026 |
$200K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,355 |
8,680 |
$196K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,541 |
3,211 |
$191K |
| 91200 |
|
1,829 |
1,720 |
$190K |
| J3490 |
Unclassified drugs |
24,788 |
8,491 |
$185K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,945 |
1,799 |
$183K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
921 |
785 |
$175K |
| 84443 |
Thyroid stimulating hormone (TSH) |
11,038 |
10,149 |
$159K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
643 |
561 |
$150K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
529 |
309 |
$144K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,286 |
3,975 |
$130K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,158 |
1,529 |
$124K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,697 |
5,555 |
$122K |
| 87522 |
Neg quan hep c or qual rna |
2,605 |
2,471 |
$112K |
| 73562 |
|
2,014 |
1,673 |
$97K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,550 |
1,494 |
$91K |
| 72131 |
|
865 |
702 |
$84K |
| 84484 |
|
9,268 |
6,422 |
$80K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,488 |
5,003 |
$80K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,176 |
2,822 |
$77K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,905 |
1,725 |
$77K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
152 |
106 |
$76K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,951 |
1,615 |
$71K |
| 80061 |
Lipid panel |
5,887 |
5,089 |
$70K |
| 86738 |
|
5,292 |
4,788 |
$67K |
| 85027 |
|
10,763 |
9,700 |
$63K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,267 |
2,907 |
$63K |
| 71250 |
|
598 |
447 |
$62K |
| 73630 |
|
2,110 |
1,846 |
$62K |
| 84703 |
|
7,591 |
6,554 |
$59K |
| 73610 |
|
1,922 |
1,523 |
$58K |
| J2704 |
Injection, propofol, 10 mg |
3,207 |
2,783 |
$56K |
| 73030 |
|
1,512 |
1,142 |
$55K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
329 |
251 |
$52K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,192 |
6,759 |
$48K |
| 78264 |
|
270 |
216 |
$47K |
| 83690 |
|
6,841 |
5,797 |
$46K |
| 81001 |
|
12,144 |
10,400 |
$46K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,623 |
2,585 |
$45K |
| 84439 |
|
4,230 |
3,938 |
$44K |
| 73130 |
|
1,424 |
1,214 |
$42K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,011 |
4,695 |
$41K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,852 |
6,259 |
$41K |
| 70486 |
|
235 |
203 |
$40K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
246 |
219 |
$40K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,082 |
712 |
$38K |
| 82607 |
|
2,443 |
2,125 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,360 |
3,086 |
$34K |
| 74018 |
|
953 |
793 |
$33K |
| J0595 |
Injection, butorphanol tartrate, 1 mg |
2,273 |
1,512 |
$33K |
| 73110 |
|
985 |
760 |
$32K |
| 97161 |
|
564 |
489 |
$31K |
| 87040 |
|
3,244 |
2,040 |
$30K |
| 87186 |
|
3,101 |
2,697 |
$29K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,384 |
1,276 |
$28K |
| 80074 |
|
696 |
602 |
$28K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
2,959 |
1,964 |
$27K |
| 93017 |
|
290 |
246 |
$26K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,904 |
1,698 |
$26K |
| 85610 |
|
5,449 |
4,692 |
$25K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,942 |
1,663 |
$25K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,387 |
1,136 |
$25K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,616 |
2,062 |
$24K |
| 83735 |
|
3,803 |
3,216 |
$24K |
| 96376 |
|
2,035 |
1,405 |
$23K |
| 86317 |
|
1,534 |
1,451 |
$22K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
773 |
567 |
$22K |
| 82728 |
|
1,733 |
1,574 |
$22K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,111 |
1,796 |
$21K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,716 |
1,104 |
$21K |
| 87088 |
|
2,400 |
2,120 |
$19K |
| 43249 |
|
15 |
12 |
$19K |
| Q9958 |
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
1,304 |
1,176 |
$18K |
| 82746 |
|
1,294 |
1,223 |
$17K |
| 87340 |
|
1,427 |
1,343 |
$17K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,667 |
1,488 |
$16K |
| 74021 |
|
559 |
429 |
$16K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
232 |
199 |
$16K |
| 76536 |
|
207 |
188 |
$15K |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
2,280 |
1,648 |
$15K |
| 82553 |
|
1,003 |
707 |
$15K |
| 83880 |
|
1,029 |
855 |
$14K |
| 81003 |
|
4,640 |
4,058 |
$14K |
| 72100 |
|
315 |
266 |
$14K |
| 00731 |
|
196 |
192 |
$13K |
| 86708 |
|
1,214 |
1,141 |
$13K |
| 86704 |
|
1,179 |
1,115 |
$13K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
973 |
801 |
$12K |
| 86038 |
|
913 |
870 |
$12K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,567 |
1,120 |
$12K |
| 83540 |
|
1,893 |
1,797 |
$12K |
| 84520 |
|
1,369 |
1,261 |
$11K |
| 82962 |
|
3,843 |
1,952 |
$11K |
| 73080 |
|
220 |
192 |
$11K |
| 97010 |
|
1,889 |
442 |
$11K |
| 87517 |
|
334 |
313 |
$11K |
| 82550 |
|
1,267 |
934 |
$11K |
| 85379 |
|
1,602 |
1,422 |
$11K |
| 83550 |
|
1,121 |
1,054 |
$10K |
| 86140 |
|
1,898 |
1,751 |
$10K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,228 |
1,079 |
$9K |
| 87807 |
|
1,115 |
1,014 |
$8K |
| 85651 |
|
1,658 |
1,515 |
$7K |
| 83605 |
|
1,217 |
931 |
$7K |
| J2785 |
Injection, regadenoson, 0.1 mg |
54 |
50 |
$7K |
| 00813 |
|
57 |
54 |
$7K |
| 73090 |
|
204 |
155 |
$6K |
| 85730 |
|
1,376 |
1,201 |
$6K |
| 84403 |
|
214 |
192 |
$5K |
| 93226 |
|
38 |
38 |
$5K |
| 73590 |
|
210 |
167 |
$5K |
| 92523 |
|
40 |
37 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
73 |
60 |
$5K |
| 84550 |
|
166 |
156 |
$4K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
138 |
99 |
$4K |
| 87070 |
|
577 |
438 |
$4K |
| 82565 |
|
1,402 |
1,281 |
$4K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
304 |
75 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
95 |
89 |
$4K |
| 85007 |
|
2,525 |
2,056 |
$3K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
481 |
242 |
$3K |
| 93971 |
|
53 |
52 |
$3K |
| 97164 |
|
110 |
94 |
$3K |
| 77080 |
|
52 |
43 |
$3K |
| 94761 |
|
676 |
580 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
82 |
76 |
$3K |
| 82805 |
|
178 |
150 |
$3K |
| 76775 |
|
48 |
38 |
$3K |
| 86707 |
|
314 |
294 |
$3K |
| 82150 |
|
291 |
271 |
$3K |
| 72192 |
|
14 |
12 |
$3K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
16 |
13 |
$3K |
| 87350 |
|
298 |
278 |
$3K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
25 |
24 |
$2K |
| 10060 |
|
15 |
12 |
$2K |
| 84402 |
|
98 |
90 |
$2K |
| 83970 |
|
59 |
53 |
$2K |
| 00811 |
|
33 |
33 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
378 |
334 |
$2K |
| 73560 |
|
29 |
29 |
$2K |
| 93225 |
|
45 |
40 |
$2K |
| 73502 |
|
57 |
53 |
$2K |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
138 |
122 |
$2K |
| 87493 |
|
42 |
38 |
$1K |
| 87205 |
|
136 |
117 |
$1K |
| 84702 |
|
75 |
66 |
$822.74 |
| 86800 |
|
48 |
45 |
$808.86 |
| 80050 |
General health panel |
98 |
80 |
$807.49 |
| 86376 |
|
61 |
57 |
$781.20 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
23 |
12 |
$717.19 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
812 |
734 |
$700.31 |
| 82043 |
|
93 |
83 |
$689.83 |
| J7050 |
Infusion, normal saline solution, 250 cc |
40 |
29 |
$582.30 |
| 90686 |
|
48 |
39 |
$553.62 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
160 |
86 |
$518.02 |
| 36600 |
|
195 |
127 |
$514.27 |
| 82375 |
|
178 |
150 |
$512.03 |
| 86803 |
|
42 |
40 |
$510.01 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
14 |
12 |
$507.08 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
16 |
15 |
$469.05 |
| 84466 |
|
43 |
40 |
$468.41 |
| 86308 |
|
17 |
13 |
$463.82 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
20 |
19 |
$406.66 |
| 96367 |
|
14 |
12 |
$374.80 |
| 86618 |
|
28 |
26 |
$370.34 |
| 86592 |
|
55 |
51 |
$319.71 |
| 89055 |
|
41 |
40 |
$312.92 |
| 90714 |
|
58 |
52 |
$302.01 |
| 87449 |
|
29 |
26 |
$300.76 |
| 83050 |
|
174 |
150 |
$293.54 |
| 84100 |
|
96 |
71 |
$292.10 |
| 87324 |
|
31 |
25 |
$276.80 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
54 |
40 |
$274.96 |
| 86021 |
|
17 |
14 |
$226.80 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
75 |
57 |
$184.04 |
| 82310 |
|
30 |
25 |
$176.30 |
| 94664 |
|
157 |
120 |
$153.73 |
| 82272 |
|
82 |
56 |
$142.14 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
46 |
43 |
$130.02 |
| 85018 |
|
206 |
180 |
$128.02 |
| J2300 |
Injection, nalbuphine hydrochloride, per 10 mg |
54 |
39 |
$127.11 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
16 |
12 |
$114.75 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
34 |
31 |
$109.31 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
25 |
24 |
$99.64 |
| J3411 |
Injection, thiamine hcl, 100 mg |
82 |
38 |
$98.61 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
54 |
49 |
$91.98 |
| 87045 |
|
16 |
12 |
$88.21 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
29 |
26 |
$83.81 |
| 94760 |
|
40 |
28 |
$62.63 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
34 |
32 |
$42.00 |
| A9578 |
Injection, gadobenate dimeglumine (multihance multipack), per ml |
13 |
12 |
$37.20 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
28 |
26 |
$13.46 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
13 |
13 |
$12.77 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,508 |
1,301 |
$0.00 |